1-2 of 2
James Godfrey
Close
Sort by
Journal Articles

Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions

Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G. Karrison, Rachel Treitman, Manali K. Kamdar, Bradley M. Haverkos, James Godfrey, Melissa A. Babcook, Timothy J. Voorhees, Sophie Carlson, Daria Gaut, Caspian Oliai, Jason T. Romancik, Allison M. Winter, Brian T. Hill, Radhika Bansal, Jose C. Villasboas Bisneto, Imran A. Nizamuddin, Reem Karmali, Lindsey A. Fitzgerald, Deborah M. Stephens, Priyanka A. Pophali, Asaad Trabolsi, Jonathan H. Schatz, Marie Hu, Veronika Bachanova, Michael J. Slade, Nathan Singh, Nausheen Ahmed, Joseph P. McGuirk, Michael R. Bishop, Peter A. Riedell, Justin Kline
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4528–4538.
https://doi.org/10.1182/bloodadvances.2023010016
Published: 2023
Includes: Supplemental data
Journal Articles

Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation

Clinical Trials & Observations
James Godfrey, Hongtao Liu, Jovian Yu, Michael Tallarico, Emily Curran, Andrew Artz, Peter A. Riedell, Wendy Stock, Theodore Karrison, Carrie Fitzpatrick, Girish Venkataraman, Alan Cooper, Sonali M. Smith, Michael R. Bishop, Justin Kline
Journal: Blood Advances
Blood Adv (2023) 7 (6): 963–970.
https://doi.org/10.1182/bloodadvances.2022008403
Published: 2023
Includes: Supplemental data